Skip to main content

Table 2 Pathological variables of patients with borderline resectable pancreatic cancer

From: Relationship between surgical R0 resectability and findings of peripancreatic vascular invasion on CT imaging after neoadjuvant S-1 and concurrent radiotherapy in patients with borderline resectable pancreatic cancer

 

N = 29

Tumor size, mm

30 [10–40]

Lymph node metastasis

11 (38%)

Portal vein invasion

10 (34%)

Plexus invasion

12 (41%)

Stage (I/II/III)

3 (10%)/26 (90%)/0

Residual tumor (R0/R1/RX)

27 (93%)/1 (3%)/1 (3%)

Evans grade (I/IIa/IIb/III/IV)

5 (17%)/16 (55%)/4 (14%)/4 (14%)/0

  1. Data are presented as n (%) or median [range]